← Eichor
Study identifier: NCT07483047 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Prediction Model for Postoperative Cognitive Dysfunction in Elderly Cardiac Patients: A Special Disease Cohort Study

Condition: Postoperative Cognitive Dysfunction (POCD) · Cardiac Diseases Requiring Surgery  ·  Sponsor: Shanghai Geriatric Medical Center

PhaseN/A
Planned participants634
Who can joinAll sexes, 65 Years to no upper limit
Healthy volunteersNo

About this study

This is a prospective cohort study aiming to construct a prediction model for postoperative cognitive dysfunction (POCD) in elderly cardiac patients. We plan to enroll elderly patients aged ≥65 years undergoing cardiac surgery. Peripheral blood samples and functional magnetic resonance imaging (fMRI) data will be collected at baseline and key time points post-surgery. The primary objectives are to identify novel peripheral blood protein biomarkers for POCD, explore the correlation between fMRI characteristics and POCD, and establish a reliable early prediction model to improve perioperative management and reduce the incidence of POCD in elderly cardiac surgical patients.

This description comes directly from the study's public registry record.

Talk to the study team

Hao Fang  ·  02164175590  ·  drfanghao@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Shanghai Geriatric Medical CenterShanghai, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07483047